Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Identification of proteomic markers for prediction of the response to 5-Fluorouracil based neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients

Fig. 1

Workflow of the total internal cohort in Chinese PLA General Hospital from 2010 to 2019. A total of 42 patients with LARC met the enrollment criteria and were divided into 3 groups based on TRG, namely total responders (TR), moderate responders (MR), and poor responders (PR). Samples from 37 patients passing quality control in protein identification were finally included in the discovery cohort for further data analysis. LARC, locally advanced rectal cancer; nCRT, neoadjuvant chemoradiation therapy; TME, total mesorectal excision; TRG, tumor regression grade

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us